Pharma & Biotech

Despite reporting a substantial quarterly loss, Madrigal Pharmaceuticals is experiencing remarkable investor enthusiasm, with its shares climbing to unprecedented levels....

In a landmark transaction that marks the end of its nearly century-long public market presence, Walgreens Boots Alliance has been...

Lexicon Pharmaceuticals faces a series of critical events this week that could significantly influence its stock trajectory. The company is...

Compass Therapeutics is experiencing significant pre-market trading activity today following the release of encouraging preclinical results for its oncology candidate...

Biolife shares face a pivotal moment with the company scheduled to release its third-quarter 2025 financial results after market close...

The biotechnology sector is watching closely as BioNTech's proposed acquisition of CureVac enters its decisive phase. With a November 25...

Biotechnology firm Ocugen faces a pivotal moment this Wednesday, November 5, 2025, as it prepares to disclose its third-quarter financial...

Eli Lilly & Company appears poised to transform the competitive landscape of the multi-billion dollar weight-loss medication sector through a...

Market analysts are turning increasingly bullish on HealthEquity as the company benefits from favorable regulatory developments and strategic product launches....

Investors are closely monitoring Coherus BioSciences as the biotechnology firm prepares to release its third-quarter 2025 financial results after market...